Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influenza Vaccination Among Three Recommended Groups in China: Economic Burden, Vaccine Hesitancy, Discrete Choice Experiment, Immunization Records, Willingness to Pay and Financing Strategies

NCT04038333 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT04038333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04038333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influenza Vaccination Among Three Recommended Groups in China: Economic Burden, Vaccine Hesitancy, Discrete Choice Experiment, Immunization Records, Willingness to Pay and Financing Strategies
Lead sponsor
Peking University
Phase
Observational
Overall status
Completed
Start date
August 1, 2019
Completion date
March 10, 2021
Enrollment
13,542 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cost of illness, health knowledge, attitudes, practice, immunization programs, influenza vaccines, influenza, human